Ramstad et al. found that in breast cancer, OX40 expression was elevated in 45% of samples resected from axillary lymph node metastases due to upregulation of lymphocytes within tumour-draining lymph nodes [46]. The gene discussed is TNFRSF4; the disease is breast carcinoma.